Weik Capital Management’s Labcorp LH Stock Holding History

Weik Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,525	Closed	-$228K	–	123
2018 Q3	$228K	Sell	1,525 -99	-6%	-$15.1K	0.11%	121
2018 Q2	$250K	Buy	1,624 +164	+11%	+$24.8K	0.12%	118
2018 Q1	$203K	Hold	1,460	–	–	0.1%	125
2017 Q4	$200K	Buy	+1,460	New	+$193K	0.09%	121
2015 Q1	–	Sell	-3,929	Closed	-$364K	–	111
2014 Q4	$364K	Hold	3,929	–	–	0.21%	78
2014 Q3	$343K	Sell	3,929 -756	-16%	-$68.3K	0.21%	81
2014 Q2	$412K	Sell	4,685 -233	-5%	-$20.2K	0.25%	74
2014 Q1	$415K	Hold	4,918	–	–	0.26%	72
2013 Q4	$386K	Hold	4,918	–	–	0.24%	75
2013 Q3	$419K	Sell	4,918 -58	-1%	-$4.88K	0.28%	66
2013 Q2	$428K	Buy	+4,976	New	+$413K	0.3%	63

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Weik Capital Management's LH Position: Q4 2018 in Review

Weik Capital Management sold out of Labcorp (LH) in Q4 2018, closing a stake of 1,525 shares — an estimated $228K sold.

Weik Capital Management first reported a position in LH in Q2 2013 and held it in 11 quarters. The position peaked at $428K in Q2 2013. 743 funds tracked by Wall St. Rank hold LH as of Q4 2018.

Weik Capital Management reported no remaining Labcorp position as of Q4 2018 after selling out during the quarter.
Weik Capital Management sold 1,525 Labcorp shares in Q4 2018, an estimated $228K.
Weik Capital Management first reported a position in Labcorp in Q2 2013 and held it in 11 quarters.
Weik Capital Management's Labcorp position peaked at $428K in Q2 2013.
743 funds tracked by Wall St. Rank held Labcorp as of Q4 2018.

Based on Weik Capital Management's 13F filing for Q4 2018, filed 12 Feb 2019.